Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-sensitive FGFR3 mutations in lung adenocarcinoma.
Chandrani P, Prabhash K, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, Noronha V, Patil V, Ramaswamy A, Karpe A, Thorat R, Chaudhari P, Ingle A, Choughule A, Dutt A. Chandrani P, et al. Among authors: thorat r. Ann Oncol. 2017 Mar 1;28(3):597-603. doi: 10.1093/annonc/mdw636. Ann Oncol. 2017. PMID: 27998968 Free PMC article.
Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.
Rajendra J, Datta KK, Ud Din Farooqee SB, Thorat R, Kumar K, Gardi N, Kaur E, Nair J, Salunkhe S, Patkar K, Desai S, Goda JS, Moiyadi A, Dutt A, Venkatraman P, Gowda H, Dutt S. Rajendra J, et al. Among authors: thorat r. Oncotarget. 2018 Jun 12;9(45):27667-27681. doi: 10.18632/oncotarget.25351. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963228 Free PMC article.
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A. Iyer P, et al. Among authors: thorat r. Int J Cancer. 2019 Apr 15;144(8):2008-2019. doi: 10.1002/ijc.31916. Epub 2018 Dec 8. Int J Cancer. 2019. PMID: 30304546 Free PMC article.
Nuclear localization of p65 reverses therapy-induced senescence.
Salunkhe S, Mishra SV, Nair J, Shah S, Gardi N, Thorat R, Sarkar D, Rajendra J, Kaur E, Dutt S. Salunkhe S, et al. Among authors: thorat r. J Cell Sci. 2021 Mar 26;134(6):jcs253203. doi: 10.1242/jcs.253203. J Cell Sci. 2021. PMID: 33526713
Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation.
Joshi A, Butle A, Hait S, Mishra R, Trivedi V, Thorat R, Choughule A, Noronha V, Prabhash K, Dutt A. Joshi A, et al. Among authors: thorat r. Transl Oncol. 2022 Aug;22:101461. doi: 10.1016/j.tranon.2022.101461. Epub 2022 May 30. Transl Oncol. 2022. PMID: 35653897 Free PMC article.
78 results